Skip to main content
logo
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.93
-0.26 (-2.32%)
May 26, 2026, 1:04 PM EDT - Market open

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $367.00K in the quarter ending March 31, 2026, a decrease of -99.83%. This brings the company's revenue in the last twelve months to $33.18M, down -84.55% year-over-year. In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth.

Revenue (ttm)
$33.18M
Revenue Growth
-84.55%
P/S Ratio
6.68
Revenue / Employee
$381,402
Employees
87
Market Cap
216.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020---
Dec 31, 201910.00M--
Dec 31, 201810.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Codexis78.09M
Atrium Therapeutics36.68M
Voyager Therapeutics36.49M
MediWound16.96M
Whitehawk Therapeutics7.15M
Camp4 Therapeutics3.93M
Humacyte2.02M
Revenue Rankings

KROS News

More News